Evaluating Safety, Tolerability, and Preliminary Efficacy of YSCH-01 Monotherapy and in Combination With Atezolizumab for Recurrent Glioblastoma
Abroad (travel likely)RecruitingEARLY_PHASE1
Conditions
Recurrent Glioblastoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Huashan Hospital, Shanghai, Shanghai Municipality, China
Contact: Principal Investigator (Zhifeng Shi, Dr.)
Study leads
Zhifeng Shi, Dr.
Principal Investigator
Huashan Hospital